Cannabis Maker to Go Public in Reverse Merger With Oil Producer

June 13, 2023 · Yahoo!Finance

A cannabis oil company is poised to go public next week in a landmark deal, sidestepping Canada’s downtrodden traditional IPO route after merging with a long-standing, listed crude producer.

Zyus Life Sciences Inc. completed a reverse takeover of Phoenix Canada Oil Co. Ltd. on June 9, raising C$20.1 million ($15.1 million). The company, which makes cannabinoid drugs to treat pain for osteoarthritis and bone cancer, is set for its trading debut as Zyus Life Sciences Corp. (ticker ZYUS CN) on Canada’s TSX-Venture Exchange on June 19, according to its press release.

“We tried to go the IPO route,” Chief Executive Officer Brent Zettl said in a phone interview. But back then, “the markets were headed south” and “there were no takers because nobody wanted to be the lead investor.”

Reverse takeovers are a popular way to go public in times of market volatility, allowing companies to negotiate directly with a handful of institutional investors, according to University of Calgary finance professor Ari Pandes.

“When you’re doing an IPO, the market can turn on you,” he said. By contrast, in a reverse takeover “you’re not trying to get wide investor participation,” which in turn can lead to lower costs for marketing a deal and less regulatory scrutiny.

Stock issuances of all types — including IPOs and secondary offerings — are down sharply in Canada this year. On the TSX-Venture, IPOs were 62% below last year’s level through the end of May, raising just C$7.8 million compared with C$116.5 million in the same period a year ago, according to data from the exchange operator TMX Group.

READ: April 19, Canada’s Listless IPO Market Has Crisis of Confidence: ECM Watch

As IPO proceeds have fallen, companies including Zyus are opting for a faster path to market — buying a company with an existing public listing rather than pursuing a new one of its own. There have been five reverse takeovers so far this year on the TSX-Venture, which is roughly the same as the year-ago period. Moreover, the Zyus deal is the largest reverse takeover on the exchange in 2023, more than double the C$9 million raised by Waroona Energy Inc. and the C$8.4 million by LSL Pharma Group Inc.

Zettl, a Canadian medical marijuana pioneer who sold CanniMed Ltd. to Aurora Cannabis Inc. for C$1.2 billion in 2018, said he’s plowed C$62 million of his own money into Zyus. The company is using the reverse takeover to fund its capital needs, he said.

“You need money and I don’t have enough for the three drugs that we have in process,” he said, adding that the company is looking to pursue further clinical trials for US Food and Drug Administration approvals for its treatments. (Full Story)

In categories:Business International
Next Post

Connecticut Latest in String of States to Enact 280E Relief

Cannabis companies will be able to deduct business expenses at the state level. Connecticut on Tuesday became the latest in a national trend of states with operational marijuana markets to approve state-level relief from the 280E provision of the federal tax code.…
Previous Post

Antigua and Barbuda Authorizes Rastafari to Grow & Consume Cannabis

The Caribbean nation of Antigua and Barbuda has granted Rastafari officials authorization to grow and consume cannabis as their faith considers the plant sacred, the Associated Press reports. In an interview with the AP, Antigua and Barbuda Prime Minister Gaston Browne said the…
Random Post

Mushroom Extract Shown to Dramatically Improve Brain-Cell Growth in The Lab

Fungi have attracted attention in recent years for their potential in aiding our brains' growth and functionality. And no, we're not just talking about the psychedelic ones. The lion's mane mushroom, for one, has long had a reputation for various mental health…
Random Post

Former Michigan Medical Cannabis Board Head Pleads Guilty to Accepting Bribes

The former head of a Michigan medical cannabis licensing board on Thursday pleaded guilty to accepting $110,000 in bribes in exchange for industry licenses, CBS News reports. Rick Johnson served as head of the board for two years and served as state…
Random Post

Oregon Issues First Psilocybin Manufacturing License

Oregon regulators issued the state’s first business license under the state’s historic psilocybin therapy program last week, the Associated Press reports. The licensee, Satori Farms PDX LLC, received its license to begin manufacturing psilocybin products from Oregon Psilocybin Services — a branch…
Random Post

Oregon Secretary Of State’s Marijuana Consulting Gig Raises Questions About New Audit On Preparing For Federal Legalization

The Oregon secretary of state’s office released an audit of the state’s regulation of the cannabis industry on Friday on the heels of revelations that the agency’s head, Shemia Fagan, accepted a side job as consultant to a cannabis company…